Design Therapeutics (DSGN) Downgraded by Zacks Investment Research to Sell

Design Therapeutics stock has undergone multiple analysts rating changes in the recent past.  Design Therapeutics Downgraded by Zacks Investment Research on 10/11/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

Shares of Design Therapeutics traded down -$0.30 on Monday, reaching $14.37. 115306 shares of the stock traded hands, compared to its average volume of 74272. Shares of Design Therapeutics were trading at $14.37 on Monday. The firm’s 50 day moving average is $15.88 and its 200 day moving average is N/A.Design Therapeutics has a 12 month low of $14.20 and a 12 month high of $50.50. While on yearly highs and lows, Design Therapeutics’s today has traded high as $15.54 and has touched $14.20 on the downward trend. See More Analyst Rating at: RATING

Design Therapeutics Earnings and What to expect: 

Design Therapeutics last announced its quarterly earnings results on August 9th, 2021. The reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.04. Design Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Design Therapeutics are expected to decrease in the coming year, from ($0.71) to ($0.94) per share. Design Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, November 8th, 2021 based off prior year’s report dates.

Earnings for Design Therapeutics are expected to decrease in the coming year, from ($0.71) to ($0.94) per share.

Design Therapeutics (DSGN) Moving Average Technical Analysis

5 day Moving Average is $14.81 And 5 day price change is -$0.99 (-6.45%)  with average volume for 5 day average is 69,140. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $15.22 and 20 day price change is -$2.01 (-12.27%) and average 20 day moving volume is 76,765. 50 day moving average is $15.88  and 50 day price change is -$1.11 ( -7.17%)  and with average volume for 50 days is : 78,652. 200 day moving average is N/A  and 200 day price change is N/A (N/A)  and with average volume for 200 days is : N/A.

Other owners latest trading in Design Therapeutics :

  • On 8/17/2021 shares held by Price T Rowe Associates Inc. MD were 1,448,968 which equates to market value of $28.17M and appx 0.00% owners of Design Therapeutics
  • On 8/17/2021 shares held by Citadel Advisors LLC were 2,566,148 which equates to market value of $49.94M and appx 0.00% owners of Design Therapeutics
  • On 8/16/2021 shares held by Bank of America Corp DE were 6,402 which equates to market value of $0.13M and appx 0.00% owners of Design Therapeutics
  • In total Institutional ownership equates to Institutional Ownership Percentage: 49.70% for Design Therapeutics

See More Analyst Rating at: RATING